"Reduction of corneal scarring in rabbits by targeting the TGFB1 pathway with a triple siRNA combination"
written by Sriniwas Sriram, Daniel Gibson, Paulette Robinson, Sonal Tuli, Alfred S. Lewin, Gregory Schultz,
published by Advances in Bioscience and Biotechnology, Vol.4 No.10C, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze
2019
[2] Corneal chemical burn treatment through a delivery system consisting of TGF-β1 siRNA: in vitro and in vivo
Drug Delivery and Translational Research, 2018
[3] siRNA delivery for treatment of degenerative diseases, new hopes and challenges
Journal of Drug Delivery Science and Technology, 2018
[4] Nanostructured lipid carriers containing rapamycin for prevention of corneal fibroblasts proliferation and haze propagation after burn injuries: In vitro and in vivo
Journal of cellular physiology, 2018
[5] Development of wound healing models to study TGFβ3's effect on SMA
Experimental Eye Research, 2017
[6] Article Commentary: Cornea as a Model for Testing CTGF-Based Antiscarring Drugs
Bone and tissue regeneration insights, 2016
[7] Cornea As a Model for Testing CTGF-Based Antiscarring Drugs
Bone and tissue regeneration insights, 2016
[8] REDUCTION OF PROFIBROTIC CONNECTIVE TISSUE GROWTH FACTOR IN WOUNDED RAT CORNEAS USING A RIBOZYME EXPRESSED IN SELF COMPLIMENTARY ADENO-ASSOCIATED VIRUS
Wound Healing, 2015
[9] Assessment of anti-scarring therapies in ex vivo organ cultured rabbit corneas
Experimental eye research, 2014
[10] Triple Combination of siRNAs Targeting TGFβ1, TGFβR2, and CTGF Enhances Reduction of Collagen I and Smooth Muscle Actin in Corneal Fibroblasts
Investigative ophthalmology & visual science, 2013
[11] Triple Combination of siRNAs Targeting TGFβ1, TGFβR2, and CTGF Enhances Reduction of Collagen I and Smooth Muscle Actin in Corneal FibroblastsTriple …
2013